Atezolizumab plus bevacizumab and chemotherapy in metastatic nonsquamous NSCLC: the randomized double-blind phase 3 IMpower151 trial

• DOI: 10.1038/s41591-025-03658-y
• Publication Date: 2025-05-16T09:02:27Z
• Authors: Caicun Zhou; Xiaorong Dong; Gongyan Chen; Zhehai Wang; Xianghua Wu; Yu Yao; Yiping Zhang; Ying Cheng; Hongming Pan; Xiaodong Zhang; Jiuwei Cui; Lifeng Wang; Xi Chen; Xiaoling Li; Ziping Wang; Qiming Wang; Jianxing He; Mengzhao Wang; Iris Yan; Li Qian; Miao Xu; Xiayu Huang; Chun Sun; Jun Cai; Qiong Wu; Marcus Ballinger; Monika Kaul; Minu K. Srivastava